Mounjaro will come in a four-dose device known as a KwikPen for people with type 2 diabetes or obesity

A new weight loss injection will be available in the UK within weeks to treat thousands of patients with type 2 diabetes or obesity, after the medicines watchdog became the first major regulator in the world to greenlight the drug in a more convenient device.

Mounjaro was developed by the US pharmaceutical company Eli Lilly. Trials show it helps those on the highest dose lose more than three stone on average. It is injected under the skin of a patient’s stomach area, thigh or upper arm, and is to be used together with a reduced-calorie diet and increased physical activity.

Continue reading…

Leave a Reply

Your email address will not be published. Required fields are marked *

You May Also Like

Digested week: Netflix bans password-sharing – but I’m close to bailing anyway | Emma Brockes

Plus, reflections on Martin Amis’s later years, and Jude Law’s disgusting new…

Stay in style: Europe’s 10 best new design hotels

From Greek islands and cool cities to a Finnish forest, these new…

Buffalo shooting: how white replacement theory keeps inspiring mass murder | Jason Stanley

This once fringe ideology, which was at the heart of Nazism, has…

Fragmented world’s rival blocs may risk new cold war, says IMF head

Warning from Kristalina Georgieva after G7 explores economic resilience, secure global supply…